What is BRTX (BRTX) stock price today?

BRTX (BRTX) is currently trading at $0.20, down 2.11% today.

What is BRTX P/E ratio?

BRTX's P/E ratio is -0.33. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BRTX return on equity (ROE)?

BRTX's return on equity (ROE) is -423.84%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is BRTX's market cap?

BRTX has a market capitalization of $1.83M.

NASDAQ · Biotechnology

BRTX (BRTX) Stock

$0.20 -2.11% NASDAQ: BRTX Healthcare

Valuation

Metric	Value
Price	$0.20
Market Cap	$1.83M
P/E Ratio	-0.33
P/B Ratio	1.19
P/S Ratio	10.05
EPS (TTM)	$0.00
52-Week High	$1.89
52-Week Low	$0.16
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-423.84%
ROA	-238.27%
ROCE	-470.16%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	-30.90%
Debt/Equity	0.01
Current Ratio	0.75

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-26.0M	$-19.0M	$-15.0M	$-12.0M	$-16.0M
Net Profit	$-44.0M	$-13.0M	$-10.0M	$-9.0M	$-14.0M
EPS	$-37.30	$-3.65	$-2.47	$-1.16	$-1.58
Op Margin	-57191.0%	-15745.8%	-10439.5%	-2881.6%	-4350.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$22.0M	$16.0M	$13.0M	$12.0M	$4.0M
Total Liabilities	$1.0M	$6.0M	$3.0M	$4.0M	$4.0M
Cash	$21.0M	$2.0M	$1.0M	$1.0M	$2.0M
Borrowings	$1.0M	$0	$0	$0	$0

Latest News

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform GlobeNewswire · Jun 25, 2026 BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth GlobeNewswire · Jun 18, 2026 BC-Most Active Stocks Associated Press · May 27, 2026 Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) CNW Group · May 27, 2026 Sector Update: Healthcare Stocks Decline Tuesday Afternoon MT Newswires · May 26, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-3.0M	$-6.0M	$-6.0M	$-8.0M	$-11.0M
Investing Cash Flow	$0	$-14.0M	$3.0M	$0	$9.0M
Financing Cash Flow	$0	$0	$0	$7.0M	$0
Net Cash Flow	$18.0M	$-19.0M	$-1.0M	$0	$1.0M
Free Cash Flow	$-3.0M	$-6.0M	$-7.0M	$-8.0M	$-11.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.05
EV / EBITDA	-0.05
FCF Yield	-330.77%
Quick Ratio	2.35
Interest Coverage	0.00
Return 1Y	-77.92%
Return 3Y	-89.60%
Return 5Y	-98.30%

Ownership

Insiders Held12.13%

Institutions Held7.31%

Institutions Float Held8.32%

Institutional Holder	Shares	Report Date
Citadel Advisors Llc	238,606	2026-03-31
Geode Capital Management, LLC	223,083	2026-03-31
UBS Group AG	99,832	2026-03-31
Wealth Alliance, LLC	40,000	2026-03-31
Vanguard Fiduciary Trust Co	39,452	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BOLT	$3.95	-0.50%	-0.26	$7.59M	0.00%
COCP	$0.92	+0.14%	-1.46	$12.68M	0.00%
DWTX	$1.81	+3.14%	1.42	$3.45M	0.00%
EDSA	$5.35	+1.90%	-8.61	$51.54M	0.00%
EVGNEvogene Ltd.	$0.54	-0.04%	-0.41	$4.67M	0.00%

About BRTX

BRTX is led by CEO Lance Alstodt, employs 11 people, headquartered in US, publicly traded since 2012.

BRTX stock trades at $0.20 with a market capitalization of $1.83M. The stock is valued at a price-to-earnings (P/E) ratio of -0.33, price-to-book of 1.19, price-to-sales of 10.05. Over the past 52 weeks the stock has ranged between $0.16 and $1.89, and currently trades 89.4% below its 52-week high.

On profitability, BRTX generates a return on equity (ROE) of -423.84%, return on capital employed of -470.16%, an operating margin of 0.00%, a net profit margin of -30.90%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides